These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 9858528)

  • 1. Regulation of the MEF2 family of transcription factors by p38.
    Zhao M; New L; Kravchenko VV; Kato Y; Gram H; di Padova F; Olson EN; Ulevitch RJ; Han J
    Mol Cell Biol; 1999 Jan; 19(1):21-30. PubMed ID: 9858528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Big mitogen-activated kinase regulates multiple members of the MEF2 protein family.
    Kato Y; Zhao M; Morikawa A; Sugiyama T; Chakravortty D; Koide N; Yoshida T; Tapping RI; Yang Y; Yokochi T; Lee JD
    J Biol Chem; 2000 Jun; 275(24):18534-40. PubMed ID: 10849446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational control of the MEF2A transcriptional regulatory protein.
    Ornatsky OI; Cox DM; Tangirala P; Andreucci JJ; Quinn ZA; Wrana JL; Prywes R; Yu YT; McDermott JC
    Nucleic Acids Res; 1999 Jul; 27(13):2646-54. PubMed ID: 10373581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors.
    Yang SH; Galanis A; Sharrocks AD
    Mol Cell Biol; 1999 Jun; 19(6):4028-38. PubMed ID: 10330143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-apoptotic wild-type Alzheimer amyloid precursor protein signaling involves the p38 mitogen-activated protein kinase/MEF2 pathway.
    Burton TR; Dibrov A; Kashour T; Amara FM
    Brain Res Mol Brain Res; 2002 Dec; 108(1-2):102-20. PubMed ID: 12480183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular smooth muscle cell proliferation requires both p38 and BMK1 MAP kinases.
    Zhao M; Liu Y; Bao M; Kato Y; Han J; Eaton JW
    Arch Biochem Biophys; 2002 Apr; 400(2):199-207. PubMed ID: 12054430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.
    Kato Y; Kravchenko VV; Tapping RI; Han J; Ulevitch RJ; Lee JD
    EMBO J; 1997 Dec; 16(23):7054-66. PubMed ID: 9384584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain.
    Kasler HG; Victoria J; Duramad O; Winoto A
    Mol Cell Biol; 2000 Nov; 20(22):8382-9. PubMed ID: 11046135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C.
    Molkentin JD; Black BL; Martin JF; Olson EN
    Mol Cell Biol; 1996 Jun; 16(6):2627-36. PubMed ID: 8649370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity.
    Molkentin JD; Li L; Olson EN
    J Biol Chem; 1996 Jul; 271(29):17199-204. PubMed ID: 8663403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1.
    Yang CC; Ornatsky OI; McDermott JC; Cruz TF; Prody CA
    Nucleic Acids Res; 1998 Oct; 26(20):4771-7. PubMed ID: 9753748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps.
    Wu Z; Woodring PJ; Bhakta KS; Tamura K; Wen F; Feramisco JR; Karin M; Wang JY; Puri PL
    Mol Cell Biol; 2000 Jun; 20(11):3951-64. PubMed ID: 10805738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MEF2A isoform is required for striated muscle-specific expression of the insulin-responsive GLUT4 glucose transporter.
    Mora S; Pessin JE
    J Biol Chem; 2000 May; 275(21):16323-8. PubMed ID: 10748204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation.
    Han J; Jiang Y; Li Z; Kravchenko VV; Ulevitch RJ
    Nature; 1997 Mar; 386(6622):296-9. PubMed ID: 9069290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca(2+)-dependent gene expression mediated by MEF2 transcription factors.
    Blaeser F; Ho N; Prywes R; Chatila TA
    J Biol Chem; 2000 Jan; 275(1):197-209. PubMed ID: 10617605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-specific activation of the atrial natriuretic factor promoter by PITX2 and MEF2A.
    Toro R; Saadi I; Kuburas A; Nemer M; Russo AF
    J Biol Chem; 2004 Dec; 279(50):52087-94. PubMed ID: 15466416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
    Zhu B; Gulick T
    Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-3-3tau associates with and activates the MEF2D transcription factor during muscle cell differentiation.
    Choi SJ; Park SY; Han TH
    Nucleic Acids Res; 2001 Jul; 29(13):2836-42. PubMed ID: 11433030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A.
    Cox DM; Du M; Marback M; Yang EC; Chan J; Siu KW; McDermott JC
    J Biol Chem; 2003 Apr; 278(17):15297-303. PubMed ID: 12586839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.
    Grégoire S; Yang XJ
    Mol Cell Biol; 2005 Mar; 25(6):2273-87. PubMed ID: 15743823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.